- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Nivolumab Injection [Opdivo]
Total 11394 results
-
Dr. Eliza HawkesBristol-Myers SquibbActive, not recruitingFollicular LymphomaAustralia
-
University of Texas Southwestern Medical CenterWithdrawnMelanoma | Metastatic MelanomaUnited States
-
Joanne JeterNational Cancer Institute (NCI)Active, not recruitingLynch Syndrome | Colon Adenoma | Colon Carcinoma | MLH1 Gene Mutation | MSH2 Gene MutationUnited States
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedBlastic Plasmacytoid Dendritic Cell Neoplasm | HTLV-1 Infection | Recurrent Mycosis Fungoides | Refractory Mycosis Fungoides | Refractory Angioimmunoblastic T-cell Lymphoma | Hepatosplenic T-Cell Lymphoma | Recurrent Adult T-Cell Leukemia/Lymphoma | Refractory Anaplastic Large Cell Lymphoma | Recurrent... and other conditionsUnited States
-
Bristol-Myers SquibbActive, not recruitingHepatocellular Carcinoma | Hepatoma | Liver Cell Carcinoma | Liver Cancer, Adult | Liver Cell Carcinoma, AdultChile, Brazil, Argentina, China, Czechia, France, Hong Kong, Japan, Korea, Republic of, Mexico, New Zealand, Poland, Romania, Singapore, Spain, Taiwan, Turkey
-
Sumitomo Pharma America, Inc.Completed
-
Barbara Ann Karmanos Cancer InstituteBristol-Myers SquibbCompletedStage III Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage IV Bladder Urothelial Carcinoma AJCC v7 | Stage II Bladder Urothelial Carcinoma AJCC v6 and v7United States
-
Robert R. McWilliams, MDBristol-Myers Squibb; Hoosier Cancer Research NetworkActive, not recruiting
-
Spanish Lung Cancer GroupCompletedNon Small Cell Lung CancerSpain
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers SquibbActive, not recruitingGastroesophageal Cancer | Immune Checkpoint InhibitionUnited States
-
NYU Langone HealthTerminated
-
Indiana UniversityCompletedPancreatic Cancer | Chronic PancreatitisUnited States
-
Bristol-Myers SquibbActive, not recruitingA Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced CancersMelanoma | CancerUnited States, Poland, Italy, Belgium, France, Australia, Canada, Germany, Spain, Sweden, Switzerland, United Kingdom
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers SquibbActive, not recruitingColorectal Adenocarcinoma | Microsatellite Stable (MSS) Colorectal AdenocarcinomasUnited States
-
Mirati Therapeutics Inc.TerminatedUrothelial Carcinoma Bladder | Urothelial Carcinoma | Urothelial Carcinoma Ureter | Urothelial Carcinoma of the Renal Pelvis and Ureter | Urothelial Carcinoma UrethraUnited States
-
University Health Network, TorontoMirati Therapeutics Inc.CompletedSquamous Cell Carcinoma of the Oral Cavity | Squamous Cell Carcinoma, Head And Neck | Squamous Cell Carcinoma MouthCanada
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Neuroendocrine Neoplasm | Metastatic Neuroendocrine Carcinoma | Metastatic Large Cell Neuroendocrine Carcinoma | Metastatic Small Cell Neuroendocrine CarcinomaUnited States, Canada
-
Sarcoma Oncology Research Center, LLCBristol-Myers SquibbRecruitingSAINT:Trabectedin, Ipilimumab and Nivolumab as First Line Treatment for Advanced Soft Tissue SarcomaAdvanced Soft Tissue Sarcoma | Metastatic Soft Tissue SarcomaUnited States
-
Bristol-Myers SquibbNektar TherapeuticsCompletedBladder Cancer | Bladder Tumor | Muscle-Invasive Bladder CancerRussian Federation, China, Germany, Italy, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Czechia, France, Greece, Israel, Mexico, Netherlands, Poland, Spain, United Kingdom
-
Technical University of MunichBristol-Myers SquibbActive, not recruitingUrinary Bladder CancerGermany
-
Bristol-Myers SquibbNektar TherapeuticsCompletedRenal Cell CarcinomaUnited States, Argentina, Brazil, Canada, France, Germany, Mexico, Russian Federation
-
Case Comprehensive Cancer CenterCompletedUrothelial CarcinomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingAcute Myeloid LeukemiaUnited States, Canada
-
Emory UniversityNational Cancer Institute (NCI); Prostate Cancer FoundationRecruitingStage IV Prostate Cancer AJCC v8 | Metastatic Prostate AdenocarcinomaUnited States
-
University of California, IrvineExelixisRecruitingHCC | Hepatocellular CarcinomaUnited States
-
Dana-Farber Cancer InstituteBiohaven Pharmaceuticals, Inc.TerminatedMelanoma | Metastatic MelanomaUnited States
-
Jounce Therapeutics, Inc.Completed
-
Ahmed Galal, MDWithdrawnB Cell LymphomasUnited States
-
LabrhaStatitecCompletedKnee OsteoarthritisFrance
-
National Cancer Institute (NCI)CompletedMetastatic Colorectal Cancer | Hepatocellular Carcinoma | Hepatocellular Cancer | Metastatic Pancreatic Cancer | Liver MetastasisUnited States
-
John KirkwoodBristol-Myers Squibb; Secura Bio, Inc.RecruitingUnresectable MelanomaUnited States
-
Sumitomo Pharma America, Inc.TerminatedFallopian Tube Cancer | Primary Peritoneal Cancer | Urothelial Carcinoma | Renal Cell Carcinoma (RCC) | Platinum-resistant Ovarian Cancer (PROC) | Serous Epithelial Ovarian CancerUnited States, Canada
-
M.D. Anderson Cancer CenterTelix Pharmaceuticals LimitedActive, not recruitingClear Cell Renal Cell Carcinoma | Advanced CancerUnited States
-
University of ChicagoBristol-Myers Squibb; Clovis Oncology, Inc.TerminatedProstate Cancer | Endometrial CancerUnited States
-
Mirati Therapeutics Inc.Bristol-Myers SquibbActive, not recruitingMetastatic Non-Squamous Non-Small Cell Lung CancerUnited States, Canada, Belgium, France, Germany, Hungary, Israel, Italy, Netherlands, Spain, Switzerland, United Kingdom
-
Vedanta Biosciences, Inc.Bristol-Myers SquibbCompletedMelanoma | Gastric Cancer | Colorectal Cancer | Metastatic Cancer | Gastroesophageal Junction AdenocarcinomaUnited States
-
Vaccitech (UK) LimitedActive, not recruitingHepatitis BKorea, Republic of, Taiwan, United Kingdom
-
University of California, DavisPharmacyclics LLC.CompletedMetastatic Renal Cell Cancer | Stage IV Renal Cell CancerUnited States
-
Istituto Ortopedico RizzoliRecruitingKnee OsteoarthritisItaly
-
Takayuki YoshinoOno Pharmaceutical Co. LtdRecruiting
-
Bristol-Myers SquibbTerminatedUrinary Bladder NeoplasmsUnited States, Argentina, Australia, Brazil, Canada, Chile, China, France, Mexico, Netherlands, Spain, United Kingdom, Italy, Hong Kong, Russian Federation
-
University of ChicagoBristol-Myers SquibbCompletedCancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal Large B-Cell Lymphoma | Refractory Primary Mediastinal Large B-Cell LymphomaUnited States
-
Vaccitech (UK) LimitedRecruitingChronic Hepatitis BTaiwan, Hong Kong, Thailand
-
NanobiotixRecruitingMetastatic Renal Cell Carcinoma | Squamous Cell Carcinoma of Head and Neck | Radiotherapy | Immunotherapy | Microsatellite Instability-High Solid Malignant Tumour | Metastasis From Malignant Tumor of Liver | Metastasis From Malignant Tumor of Cervix | Metastasis From Malignant Melanoma of Skin (Disorder) and other conditionsUnited States
-
Yana NajjarBristol-Myers Squibb; PfizerActive, not recruitingUnresectable Melanoma | Advanced MelanomaUnited States
-
Patrick BolandBristol-Myers Squibb; Hoosier Cancer Research Network; Bavarian NordicActive, not recruitingMetastatic Colorectal CancerUnited States
-
Ultimovacs ASACompletedMalignant MelanomaUnited States, Belgium, United Kingdom, Norway
-
Radboud University Medical CenterBristol-Myers SquibbActive, not recruitingProstatic Neoplasms, Castration-ResistantNetherlands
-
Hoffmann-La RocheActive, not recruitingAdvanced or Metastatic Esophageal Squamous Cell CarcinomaKorea, Republic of, Argentina, Denmark, France, Spain, Brazil, United Kingdom, Turkey, Czechia, Thailand, Russian Federation, Italy, Poland, Taiwan, Singapore, Ukraine, Kenya, Hungary